Craft
AbbVie

AbbVie

Manufacturing Facilities

19

FY, 2021

Revenue

$56.2 B

FY, 2021

Market Capitalization

$239.6 B

2022-08-30

AbbVie Summary

Company summary

Overview
AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs. Its products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. The company sells its products directly to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers.
Type
Public
Founded
2012
HQ
Lake Bluff, IL, US | view all locations
Website
https://www.abbvie.com/
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Richard A. Gonzalez

    Richard A. Gonzalez, Chairman of the Board and Chief Executive Officer

  • Rae L. Livingston

    Rae L. Livingston, Chief Equity Officer

  • Laura J. Schumacher

    Laura J. Schumacher, Vice Chairman, External Affairs and Chief Legal Officer

  • Henry O. Gosebruch

    Henry O. Gosebruch, Executive Vice President, Chief Strategy Officer

Operating MetricsView all

Patients

52M

FY, 2019

Research and Development Centers

14
75.0%

FY, 2020

Manufacturing Facilities

19
20.8%

FY, 2021

LocationsView all

66 locations detected

  • Lake Bluff, IL HQ

    United States

    1 Waukegan Rd

  • Cambridge, MA

    United States

    200 Sidney St

  • Mettawa, IL

    United States

    26525 Riverwoods Blvd

  • North Chicago, IL

    United States

    1401 Sheridan Rd

  • Redwood City, CA

    United States

    1500 Seaport Blvd

  • South San Francisco, CA

    United States

    450 E Jamie Ct

and 60 others

AbbVie Financials

Summary financials

Revenue (Q2, 2022)
$14.6B
Gross profit (Q2, 2022)
$10.4B
Net income (Q2, 2022)
$928.0M
Cash (Q2, 2022)
$8.5B
EBIT (Q2, 2022)
$3.3B
Enterprise value
$304.0B

Footer menu